Back
NLS Pharmaceutics Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
14
NLSP
NLS Pharmaceutics
Last Price:
4.00
Seasonality Move:
22.75%
Buy
66
CRSP
CRISPR Therapeutics AG
Last Price:
51.55
Seasonality Move:
24.62%
Sell
14
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.94. The Score for NLSP is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
66
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $51.59. The Score for CRSP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- CRSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $51.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 40.56 | Sell |
| Chaikin Money Flow: | -13478 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.97 - 4.97) | Sell |
| Bollinger Bands (100): | (4.75 - 7.89) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 60.89 | Buy |
| Chaikin Money Flow: | 37582 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.13 - 50.21) | Buy |
| Bollinger Bands (100): | (45.92 - 54.96) | Buy |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.97 | Sell |
| 20-day SMA: | 4.38 | Sell |
| 50-day SMA: | 4.91 | Sell |
| 200-day SMA: | 8.06 | Sell |
| 8-day EMA: | 4.07 | Sell |
| 20-day EMA: | 4.32 | Sell |
| 50-day EMA: | 4.99 | Sell |
| 200-day EMA: | 9.86 | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.03 | Buy |
| 20-day SMA: | 48.87 | Buy |
| 50-day SMA: | 47.44 | Buy |
| 200-day SMA: | 57.94 | Sell |
| 8-day EMA: | 50.41 | Buy |
| 20-day EMA: | 49.12 | Buy |
| 50-day EMA: | 48.74 | Buy |
| 200-day EMA: | 53.78 | Sell |
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.16 per share, and an increase next year of $0.12 per share.
NLS Pharmaceutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||